Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance
Abstract Immune checkpoint inhibitors (ICIs) have changed perspectives for patients with cancer, but come with severe immune-related adverse events (irAEs). To prevent fatality or chronicity, these irAEs are often promptly treated with high-dose immunosuppressants. Until recently, evidence on the ef...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2023-05-01
|
| coleção: | npj Precision Oncology |
| Acesso em linha: | https://doi.org/10.1038/s41698-023-00380-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|